Novartis AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	291,470	263,077	192,196	206,386	181,968	184,986
Market Cap Growth	27.79%	36.88%	-6.88%	13.42%	-1.63%	-8.27%
Enterprise Value	331,927	287,363	210,220	218,480	191,083	187,917
Last Close Price	159.90	137.87	97.31	100.97	85.85	82.77
PE Ratio	21.54	19.28	16.58	14.22	27.08	7.79
PS Ratio	5.15	4.64	3.72	4.42	4.19	4.21
PB Ratio	7.49	5.70	4.36	4.42	3.07	2.73
P/TBV Ratio	-	-	-	-	-	48.24
P/FCF Ratio	16.62	14.95	11.83	15.40	13.66	13.21
P/OCF Ratio	15.20	13.74	10.91	14.27	12.78	12.27
EV/Sales Ratio	5.87	5.07	4.06	4.68	4.40	4.27
EV/EBITDA Ratio	14.48	16.29	10.18	12.04	12.81	12.03
EV/EBIT Ratio	18.02	16.29	14.45	22.36	24.05	18.69
EV/FCF Ratio	18.93	16.33	12.93	16.31	14.35	13.42
Debt / Equity Ratio	1.00	0.64	0.52	0.43	0.37	0.36
Debt / EBITDA Ratio	2.09	2.01	1.52	1.46	1.88	1.99
Debt / FCF Ratio	2.68	2.02	1.93	1.97	2.10	2.22
Net Debt / Equity Ratio	1.04	0.52	0.41	0.26	0.15	0.04
Net Debt / EBITDA Ratio	1.78	1.35	0.87	0.66	0.61	0.18
Net Debt / FCF Ratio	2.28	1.36	1.10	0.90	0.68	0.20
Asset Turnover	0.49	0.53	0.51	0.43	0.35	0.34
Inventory Turnover	2.22	2.28	2.20	1.91	1.67	1.70
Quick Ratio	0.53	0.76	0.73	0.83	0.95	1.21
Current Ratio	0.85	1.12	1.04	1.16	1.29	1.51
Return on Equity (ROE)	31.62%	30.81%	26.28%	16.15%	9.51%	36.80%
Return on Assets (ROA)	12.85%	14.14%	12.59%	8.44%	5.37%	7.23%
Return on Invested Capital (ROIC)	19.74%	22.75%	21.07%	14.43%	9.63%	12.21%
Return on Capital Employed (ROCE)	20.16%	22.44%	19.77%	12.03%	8.35%	10.25%
Earnings Yield	4.64%	5.19%	6.03%	7.03%	3.69%	12.84%
FCF Yield	6.02%	6.69%	8.46%	6.49%	7.32%	7.57%
Dividend Yield	1.93%	2.92%	3.88%	3.46%	4.01%	3.97%
Payout Ratio	44.14%	55.91%	63.85%	48.86%	107.92%	30.67%
Buyback Yield / Dilution	3.79%	3.93%	2.72%	4.78%	2.79%	1.57%
Total Shareholder Return	5.72%	6.86%	6.61%	8.24%	6.80%	5.54%

SEC Filings: 10-K · 10-Q